netscientific
  • ABOUT US
  • TEAM
    • CAREERS
  • PORTFOLIO
  • INVESTORS
    • RNS & RNS REACH
    • FINANCIAL RESULTS
    • CORPORATE GOVERNANCE
  • NEWS
    • RESEARCH REPORTS
  • 2021 GM NOTICE
  • CONTACT US
netscientific
netscientific
  • ABOUT US
  • TEAM
    • CAREERS
  • PORTFOLIO
  • INVESTORS
    • RNS & RNS REACH
    • FINANCIAL RESULTS
    • CORPORATE GOVERNANCE
  • NEWS
    • RESEARCH REPORTS
  • 2021 GM NOTICE
  • CONTACT US

Notice of Results

May 9, 2022
-
News, RNS Announcements

NetScientific plc

(“NetScientific”, the “Group” or the “Company”)

Notice of Results

Investor Presentation

NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, will announce results for the year ended 31 December 2021 on Thursday 12 May.

 

Analyst Briefing: 09.30, Thursday 12 May

Management will be hosting a remote presentation via web conference on the day of the results at 09.30 BST. Analysts wishing to join should register their interest by emailing netscientific@walbrookpr.com or by telephoning 020 7933 8780.

 

Investor Presentation: 16.00, Thursday 12 May

The Company will be hosting a presentation to discuss the results through the digital platform, Investor Meet Company, at 16.00 on the day of the results.

 

Questions can be submitted pre-event to netscientific@walbrookpr.com, or in real time during the presentation, via the “Ask a Question” function.  Whilst the Company may not be in a position to answer every question it receives, it will address the most prominent within the confines of information already disclosed to the market through regulatory notifications. Responses to the Q&A from the live presentation will be published at the earliest opportunity on the IMC platform.

 

Investors can sign up to Investor Meet Company for free and add to meet NetScientific via the following link https://www.investormeetcompany.com/netscientific-plc/register-investor

 

Those investors who have already registered with Investor Meet Company will automatically be invited.

 

A copy of the presentation will be made available on the Company’s website shortly after the presentation.

 

For more information, please contact:

 

NetScientific Via Walbrook PR
Ilian Iliev, CEO  
   
WH Ireland (NOMAD, Financial Adviser and Broker)  
Chris Fielding / Darshan Patel +44 (0)20 7220 1666
   
Walbrook PR +44 (0)20 7933 8780 or netscientific@walbrookpr.com
Nick Rome / Tom Cooper 07748 325 236 / 07971 221 972

 

 

About NetScientific

NetScientific plc (AIM: NSCI) is a holding company, that invests in, develops, commercialises and realises shareholder value in life sciences/healthcare, sustainability and technology companies, which offer significant growth potential predominately in the UK and USA, as well as globally.

 

With the acquisition of EMV Capital in August 2020, the Group doubled its portfolio from 8 to 17 companies, either through direct subsidiary, balance sheet investment or capital under advisory, varying from start-up private companies to publicly listed equities.

 

NetScientific delivers shareholder returns through a proactive and hands-on management approach to their portfolio companies; identifying, investing in, and helping to build game-changing companies. The Group targets value inflection points and the release of value through partial or full exits from trade sales, public listings, or equity sales. The Company has a strong transatlantic and growing international presence, providing attractive expansion prospects.

 

NSCI can deploy a capital-light investment structure; utilising the power of the PLC Brand, and the NetScientific balance sheet to anchor future investments and achieve a multiplier effect by attracting 3rd party investment for the portfolio companies.

 

NetScientific is headquartered in London, United Kingdom, and was admitted to trading on AIM, a market operated by the London Stock Exchange, in 2013 (website: netscientific.net).

 

Share on FacebookShare on TwitterShare on Linkedin
← PREVIOUS POST
PDS Biotech Provides Business Update and Reports First Quarter 2022 Financial Results
NEXT POST →
NetScientific acquires of 30% of Vortex Biotech Holdings

 

NetScientific plc

Level 39,
One Canada Square,
London, E14 5AB

Tel: +44 20 3514 1800
www.netscientific.net
info@netscientific.net

  • RNS & RNS Reach
  • Financial Results
  • Financial Calendar
  • Corporate Governance
  • News
  • Historic Material
Copyright
Terms of Use
Notice of Results - NetScientific
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT